Division of Cardiovascular Medicine, Department of Cardiovascular Medicine, University Hospitals Cleveland Medical Center and UH Harrington Heart and Vascular Institute, Cleveland, Ohio, USA.
Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
J Hypertens. 2019 Feb;37(2):229-252. doi: 10.1097/HJH.0000000000002019.
This article is a comprehensive document on the diagnosis and management of fibromuscular dysplasia (FMD) which was commissioned by the Working Group 'Hypertension and the Kidney' of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM). This document updates previous consensus documents/scientific statements on FMD published in 2014 with full harmonization of the position of European and US experts. In addition to practical consensus-based clinical recommendations, including a consensus protocol for catheter-based angiography and percutaneous angioplasty for renal FMD, the document also includes the first analysis of the European/International FMD Registry and provides updated data from the US Registry for FMD. Finally, it provides insights on ongoing research programs and proposes future research directions for understanding this multifaceted arterial disease.
这是一篇由欧洲高血压学会（ESH）工作组“高血压与肾脏”和血管医学学会（SVM）委托撰写的关于纤维肌性发育不良（FMD）的诊断和治疗的综合文件。该文件对 2014 年发表的关于 FMD 的以前的共识文件/科学声明进行了更新，充分协调了欧洲和美国专家的立场。除了基于共识的实用临床建议，包括用于肾 FMD 的基于导管的血管造影和经皮血管成形术的共识方案外，该文件还包括对欧洲/国际 FMD 登记处的首次分析，并提供了 FMD 的美国登记处的更新数据。最后，它提供了对正在进行的研究计划的深入了解，并为理解这种多方面的动脉疾病提出了未来的研究方向。
